FilingReader Intelligence
Ajanta Pharma reports strong FY25 results, AGM set for July 17th
June 27, 2025 at 09:32 AM UTC•By FilingReader AI
Ajanta Pharma (BSE: AJANTPHARM) has announced its financial results for the fiscal year 2025, reporting a revenue increase of 10% to INR 4,648 cr. EBITDA rose 7% to INR 1,260 cr, with a 27% margin, while profit after tax increased 13% to INR 920 cr, resulting in a PAT margin of 20%.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:AJANTPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Ajanta Pharma publishes news
Free account required • Unsubscribe anytime